Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Medulloblastoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Juvenile 2 HIV Infections 2 Ganglioneuroblastoma 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-Related Complex 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Tumor Virus Infections 1 Thrombocytopenia 1 Sezary Syndrome 1 Rhabdoid Tumor 1 Recurrence 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pinealoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

aldesleukin 65 Cyclophosphamide 45 fludarabine phosphate 30 fludarabine 27 Interleukin-2 24 incomplete Freund's adjuvant 22 Ipilimumab 17 Specimen Handling 14 MART-1 Antigen 14 CTLA-4 Antigen 14 sargramostim 13 Magnetic Resonance Spectroscopy 13 Biopsy 13 montanide ISA 51 11 Nivolumab 11 Filgrastim 11 Sorafenib 10 Interferon-alpha 9 trametinib 8 pembrolizumab 8 dabrafenib 8 Sirolimus 7 Bevacizumab 7 temsirolimus 6 Temozolomide 6 Taxes 5 Paclitaxel 5 Introns 5 Gene Expression Profiling 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Melanoma × Isotretinoin × Clear all

NCT00025012 2013-06-19

Isotretinoin in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase NA Completed

Carcinoma, Basal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡